ELOCP35

Q-omics provides the consensus-scored ELOCP35 profile across patient tissues and cancer cell-line models. ELOCP35 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in ESCA. Additionally, ELOCP35 RNA expression shows 531 significant mutation-linked associations, with the highest sampling consensus in STAD. Together, these results highlight ESCA, and STAD as cancer lineages where ELOCP35 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes ELOCP35 survival associations across molecular data types. ELOCP35 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

ELOCP35 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	ESCA (36)	view →

This table ranks reproducible ELOCP35 RNA expression–survival associations across cancer types. High ELOCP35 expression shows unfavorable associations in ESCA. The ESCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .003). Together, the overview and detailed table identify ESCA as the clearest survival context for ELOCP35 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →

Pink = unfavorable, green = favorable. all 1 lineages →

ELOCP35-ESCA (OS)

Explore this curve interactively →